Lassman, A. B., Hoang-Xuan, K., Polley, M.-Y. C., Brandes, A. A., Cairncross, J. G., Kros, J. M., Ashby, L. S., Taphoorn, M. J. B., Souhami, L., Dinjens, W. N. M., Laack, N. N., Kouwenhoven, M. C. M., Fink, K. L., French, P. J., Macdonald, D. R., Lacombe, D., Won, M., Gorlia, T., Mehta, M. P., & van den Bent, M. J. (2022). Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. Journal of Clinical Oncology, 40(23), 2539–2545. https://doi.org/10.1200/jco.21.02543
Subjects:
Brain Neoplasms
(MeSH)
Oligodendroglioma
(MeSH)
Publication Type:
Article
Unique ID:
10.1200/JCO.21.02543
PMID:
DOI:
Journal:
Publication Date:
Data Source:
Scopus